Your browser doesn't support javascript.
loading
Effectiveness of favipiravir (T-705) against wild-type and oseltamivir-resistant influenza B virus in mice.
Fang, Qiong-Qiong; Huang, Wei-Juan; Li, Xi-Yan; Cheng, Yan-Hui; Tan, Min-Ju; Liu, Jia; Wei, He-Jiang; Meng, Yao; Wang, Da-Yan.
  • Fang QQ; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, 102206, China. Electronic address: fangqiongqiong@cnic.org.cn.
  • Huang WJ; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, 102206, China.
  • Li XY; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, 102206, China.
  • Cheng YH; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, 102206, China.
  • Tan MJ; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, 102206, China.
  • Liu J; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, 102206, China.
  • Wei HJ; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, 102206, China.
  • Meng Y; Shaanxi Provincial Center for Disease Control and Prevention, Xi'an, 710054, China.
  • Wang DY; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, 102206, China. Electronic address: dayanwang@cnic.org.cn.
Virology ; 545: 1-9, 2020 06.
Article en En | MEDLINE | ID: mdl-32174453
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Virus de la Influenza B / Pirazinas / Farmacorresistencia Viral / Gripe Humana / Oseltamivir / Amidas Límite: Animals / Female / Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Virus de la Influenza B / Pirazinas / Farmacorresistencia Viral / Gripe Humana / Oseltamivir / Amidas Límite: Animals / Female / Humans Idioma: En Año: 2020 Tipo del documento: Article